Cannara Biotech Inc.
LOVFF
$1.34
-$0.02-1.47%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 72.88M | 67.78M | 63.93M | 60.02M | 56.76M |
| Total Other Revenue | -40.50K | 10.70K | 10.70K | 10.70K | -70.70K |
| Total Revenue | 72.84M | 67.74M | 63.89M | 59.98M | 56.64M |
| Cost of Revenue | 40.51M | 39.47M | 40.82M | 38.23M | 35.37M |
| Gross Profit | 32.33M | 28.27M | 23.07M | 21.74M | 21.27M |
| SG&A Expenses | 15.69M | 15.19M | 15.39M | 14.45M | 13.38M |
| Depreciation & Amortization | 925.20K | 942.00K | 913.90K | 1.01M | 740.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.68M | 56.28M | 57.92M | 54.52M | 50.37M |
| Operating Income | 15.17M | 11.46M | 5.97M | 5.46M | 6.27M |
| Income Before Tax | 12.40M | 9.77M | 3.90M | 3.24M | 3.94M |
| Income Tax Expenses | 1.26M | 90.60K | -898.00K | -1.43M | -- |
| Earnings from Continuing Operations | 11.14 | 9.68 | 4.80 | 4.66 | 3.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.14M | 9.68M | 4.80M | 4.66M | 3.94M |
| EBIT | 15.17M | 11.46M | 5.97M | 5.46M | 6.27M |
| EBITDA | 19.43M | 15.93M | 10.39M | 9.94M | 10.48M |
| EPS Basic | 0.12 | 0.11 | 0.05 | 0.05 | 0.04 |
| Normalized Basic EPS | 0.08 | 0.06 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.12 | 0.10 | 0.05 | 0.04 | 0.04 |
| Normalized Diluted EPS | 0.08 | 0.05 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 362.03M | 360.62M | 360.08M | 360.28M | 362.90M |
| Average Diluted Shares Outstanding | 367.96M | 366.88M | 364.64M | 364.08M | 365.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |